Edge Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,150
| Closed | -$14K | – | 607 |
|
|
2020
Q2 | $14K | Hold |
1,150
| – | – | ﹤0.01% | 419 |
|
|
2020
Q1 | $10K | Buy |
1,150
+900
| +360% | +$7.83K | ﹤0.01% | 400 |
|
|
2019
Q4 | $2K | Hold |
250
| – | – | ﹤0.01% | 538 |
|
|
2019
Q3 | $1K | Hold |
250
| – | – | ﹤0.01% | 555 |
|
|
2019
Q2 | $2K | Hold |
250
| – | – | ﹤0.01% | 525 |
|
|
2019
Q1 | $4K | Hold |
250
| – | – | ﹤0.01% | 482 |
|
|
2018
Q4 | $4K | Sell |
250
-200
| -44% | -$3.2K | ﹤0.01% | 494 |
|
|
2018
Q3 | $10K | Sell |
450
-150
| -25% | -$3.33K | ﹤0.01% | 434 |
|
|
2018
Q2 | $15K | Hold |
600
| – | – | ﹤0.01% | 376 |
|
|
2018
Q1 | $10K | Hold |
600
| – | – | ﹤0.01% | 382 |
|
|
2017
Q4 | $11K | Sell |
600
-35
| -6% | -$642 | ﹤0.01% | 371 |
|
|
2017
Q3 | $11K | Sell |
635
-200
| -24% | -$3.47K | ﹤0.01% | 356 |
|
|
2017
Q2 | $27K | Sell |
835
-80
| -9% | -$2.59K | 0.01% | 268 |
|
|
2017
Q1 | $29K | Buy |
915
+400
| +78% | +$12.7K | 0.01% | 251 |
|
|
2016
Q4 | $19K | Sell |
515
-8,193
| -94% | -$302K | 0.01% | 281 |
|
|
2016
Q3 | $401K | Buy |
8,708
+2,120
| +32% | +$97.6K | 0.17% | 78 |
|
|
2016
Q2 | $329K | Buy |
6,588
+6,360
| +2,789% | +$318K | 0.14% | 86 |
|
|
2016
Q1 | $12K | Buy |
+228
| New | +$12K | 0.01% | 272 |
|
|
2013
Q3 | – | Sell |
-90,579
| Closed | -$3.55M | – | 360 |
|
|
2013
Q2 | $3.55M | Buy |
+90,579
| New | +$3.55M | 2.37% | 19 |
|